SIGMACEF-TAZO INJ.

1. SIGMACEF-TAZO 562.5 mg

Indications

• Lower Respiratory tract infections (LRTI)
• Skin Infection
• Bactrial septicaemia
• Bone & joint Infection
• Meningitis
• Pelvic Inflammatory disease

Dose

• Dogs & calf:- 15-25 mg b.wt. dailyIM/IV for 3 to 5 days

Composition

Each Vial contains :

•  Ceftriaxone I.P.                        500 mg
• Tazobactam Sodium               62.50 mg

Packing

• 562.50mg Vial with 5 ml DW